Bank Of New York Mellon Corp Edwards Lifesciences Corp Transaction History

Bank Of New York Mellon Corp

$528 Trillion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$74.26 - $84.51 $1.35 Billion - $1.54 Billion	18,220,013 New	18,220,013 $0
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $1.31 Billion - $1.68 Billion	19,209,965 New	19,209,965 $1.43 Billion
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $112 Million - $146 Million	-1,363,348 Reduced 6.3%	20,267,638 $1.67 Billion
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $18.6 Million - $27.6 Million	-215,556 Reduced 0.99%	21,630,986 $2.06 Billion
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $35 Million - $44.1 Million	-343,679 Reduced 1.55%	21,846,542 $2.57 Billion
Q4 2021 Feb 11, 2022	SELL	$106.37 - $130.68 $14.6 Million - $17.9 Million	-137,006 Reduced 0.61%	22,190,221 $2.87 Billion
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $106 Million - $126 Million	-1,030,088 Reduced 4.41%	22,327,227 $2.53 Billion
Q2 2021 Aug 11, 2021	BUY	$83.84 - $104.76 $15.6 Million - $19.5 Million	186,344 Added 0.8%	23,357,315 $2.42 Billion
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $109 Million - $126 Million	1,387,141 Added 6.37%	23,170,971 $1.94 Billion
Q4 2020 Feb 09, 2021	BUY	$71.69 - $91.23 $84.7 Million - $108 Million	1,181,085 Added 5.73%	21,783,830 $1.99 Billion
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $17.3 Million - $22.5 Million	257,592 Added 1.27%	20,602,745 $1.64 Billion
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $794 Million - $1.06 Billion	13,794,673 Added 210.59%	20,345,153 $1.41 Billion
Q1 2020 May 06, 2020	BUY	$52.41 - $81.0 $18.2 Million - $28.1 Million	346,555 Added 5.59%	6,550,480 $412 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $20.2 Million - $23.1 Million	-281,707 Reduced 4.34%	6,203,925 $482 Million
Q3 2019 Nov 07, 2019	SELL	$61.55 - $75.43 $20.3 Million - $24.8 Million	-329,208 Reduced 4.83%	6,485,632 $475 Million
Q2 2019 Aug 12, 2019	SELL	$55.74 - $64.41 $5.54 Million - $6.4 Million	-99,394 Reduced 1.44%	6,814,840 $1.26 Billion
Q1 2019 May 14, 2019	SELL	$47.89 - $64.05 $6.72 Million - $8.98 Million	-140,253 Reduced 1.99%	6,914,234 $1.32 Billion
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $12 Million - $14.8 Million	-259,623 Reduced 3.55%	7,054,487 $1.08 Billion
Q3 2018 Nov 09, 2018	SELL	$45.7 - $58.03 $6.91 Million - $8.77 Million	-151,180 Reduced 2.03%	7,314,110 $0
Q2 2018 Aug 06, 2018	SELL	$42.45 - $51.3 $21.5 Million - $26 Million	-506,614 Reduced 6.35%	7,465,290 $1.09 Billion
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $14.5 Million - $18.6 Million	390,980 Added 5.16%	7,971,904 $1.11 Billion
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $256 Million - $299 Million	7,580,924	7,580,924 $854 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account